FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REVUMENIB CITRATE
异名/同义词2-((4-(7-((TRANS-4-(ETHANESULFONAMIDO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NONAN-2-YL)PYRIMIDIN-5-YL)OXY)-N-ETHYL-5-FLUORO-N-(PROPAN-2-YL)BENZAMIDE-2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID MONOHYDRATE
BENZAMIDE, N-ETHYL-2-((4-(7-((TRANS-4-((ETHYLSULFONYL)AMINO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-5-FLUORO-N-(1-METHYLETHYL)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE, HYDRATE (1:1:1)
REVUMENIB CITRATE
REVUMENIB CITRATE [USAN]
REVUMENIB MONOCITRATE MONOHYDRATE
CAS登记号2761046-45-9
物质唯一标识(Unique Ingredient Identifier)YL4RYN734D
分子式C32H47FN6O4S.C6H8O7.H2O
国际化合物标识(International Chemical Identifier,InChI)UBXFWTFPYATLBT-SGBGZXBGSA-N
SMILESC1[C@H](CC[C@@H](C1)CN2CCC3(CC2)CN(c4ncncc4Oc5c(C(=O)N(CC)C(C)C)cc(cc5)F)C3)NS(CC)(=O)=O.OC(CC(=O)O)(CC(=O)O)C(=O)O.O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
    扩展资源
    ©2006-2024 Drugfuture->FDA Global Substance Registration System